Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Go back to Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
(NASDAQ: PRAX) Delayed: 298.95 -11.52 (3.71%)
Previous Close $310.47    52 Week High
Open $312.76    52 Week Low
Day High $314.01    P/E N/A 
Day Low $295.71    EPS
Volume 829,853